ASH 2014: Novel treatments for mantle cell lymphoma

Dr Jia Ruan (Weill Cornell Medical College, New York, NY) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses novel combination therapies that are currently being investigated in the clinic to address the unmet need in mantle cell lymphoma treatment. These therapeutic agents include bortezomib, lenalidomide, ibrutinib and rituximab.

Year of Production:
Running Time:
Color/Sound:

2015
2:23
Color/Sound

Comments are closed.